CD8A and neoplasm: PD-1 expression on CD8+ TILs was significantly decreased after α-PD-L1 mAb treatment suggesting that tumor cells are no longer co-opting the use of PD-1 to suppress T cell function (Figure 1C), either through downregulation of expression or via ineffective activation to initially upregulate this receptor.